APOB and colorectal carcinoma: In addition, we also identified an upregulated expression of apolipoprotein B mRNA-editing enzyme 3 (APOBEC3) which has been reported to be involved in innate and adaptive immunity (49, 50), and its induced mutagenesis is closely correlated with the response to immunotherapy (20), including CRC (51).